The No1 Ethical retailer for Books, CD’s, DVD’s & Games
30 Day Refund Guarantee

Novel Therapeutic Targets for Anti-Arrhythmic Drugs

Novel Therapeutic Targets for Anti-Arrhythmic Drugs

by George Edward Billman (Author)

  • New

    Hardcover 2010

    $214.56
Synopsis

This book provides a comprehensive overview of several promising novel drug targets and approaches against arrhythmias, with particular emphasis placed on malignant ventricular arrhythmias. The individual chapters address a single treatment strategy written by a leading expert on the chapter -- including arrhythmia mechanisms, kinase inhibitors, calcium and potassium channel targets, and atrial selective drugs.

$214.56

Quantity

20+ in stock

More Information

Format: Hardcover
 Pages: 586
 Publisher: Wiley-Blackwell
Published: 26 Jan 2010
ISBN 10: 0470261005
ISBN 13: 9780470261002

Media Reviews
In Summary, the book is a good, comprehensive reference for knowledge on arrhythmia and its treatment, and is considered as worthwhile addition to the literature on cardiac arrhythmia and antiarrhythmic drugs. (ChemMedChem, July 2010)
Author Bio
George Edward Billman is a professor at The Ohio State University. He is currently an Associate Editor of Pharmacology and Therapeutics , an Editor of Experimental Physiology , and on the editorial boards of Jo urnal of Cardiovascular Pharmacology and Journal of Applied Physiology . Dr. Billman has authored over 125 journal articles and has been an invited speaker at twenty national and international scientific meetings. He wrote the chapter Cardiac Sarcolemmal ATP-Sensitive Potassium Channel Antagonists in Drug Discovery Handbook (Wiley).